Tekla Capital Management
Investor profile
Venture capital
Also recorded as: Tekla Capital Investment LLC
Deals
5
distinct rounds
Companies
4
backed
Active span
2018–2023
6 yrs
Total round €
€359M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Earlybird Venture Capital2
- Andera Partners1
- ATEM1
- Bay City Capital1
- British Patient Capital1
- Brunnur Ventures1
- BVCF Management1
- Crédit Agricole Création1
- CTI Life Sciences1
- EQT Life Sciences1
- Fidelity Management & Research Company LLC1
- Fountain Healthcare Partners1
- HealthCap1
- Hyfinity Investments1
- Innobio 21
- Intermediate Capital Group1
- Janus Henderson Investors1
- Jeito Capital1
- Kurma Partners1
- Mass General Brigham Ventures1
- Monashee Investment Management LLC1
- Nan Fung Life Sciences1
- Novartis Venture Fund1
- Novo Holdings1
- OrbiMed1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Quell Therapeutics | UK | 1 | €138M |
| Amolyt Pharma | France | 1 | €129M |
| Oculis | Switzerland | 2 | €62M |
| Priothera Limited | Ireland | 1 | €30M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Amolyt Pharma | Series C | €129M | 2023-01 |
| Oculis | Series C | €48M | 2021-05 |
| Priothera Limited | Series A | €30M | 2020-10 |
| Oculis | Series B | €14M | 2018-12 |